-transparent.png){kind=logo}
Heparin inhibited haemagglutination by porcine reproductive and respiratory syndrome virus (PRRSV) and by Aujesky's disease virus, but failed to inhibit haemagglutination by parainfluenza virus type 3. The minimal inhibitory concentration of heparin required to inhibit 8 HA U of PRRSV haemagglutinin ranged from 0.1 to 1 U ml-1. Mouse erythrocytes failed to combine with the haemagglutination inhibitory factor of heparin. However, mouse erythrocytes treated with heparinase had greatly reduced agglutinability by PRRSV. The formation of a haemagglutinin-heparin complex could be observed by sedimenting heparin with the haemagglutinin. All these findings suggest that a heparin-like molecule on the surface of mouse erythrocytes serves as the virus-cell receptor.
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
July 2000,
Animal reproduction science,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
August 2006,
Theriogenology,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
January 2001,
Advances in experimental medicine and biology,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
June 2012,
Current opinion in virology,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
April 1997,
Veterinary microbiology,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
December 2004,
Veterinary immunology and immunopathology,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
May 1996,
The Veterinary record,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
April 2019,
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
August 2003,
Emerging infectious diseases,
E R Jusa, and
Y Inaba, and
M Kono, and
T Asagoe, and
K Uwatoko
January 2019,
Antiviral therapy,
